| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of Metastatic Colorectal Cancer Patients’ Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment
|
Heinemann, Volker
|
|
|
21 |
2 |
p. 122-131
|
artikel
|
| 2 |
Colorectal Cancer Screening in the Elderly: Is Age Just a Number?
|
Alswealmeen, Waed
|
|
|
21 |
2 |
p. e113-e116
|
artikel
|
| 3 |
Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report
|
Druet, Amaury
|
|
|
21 |
2 |
p. e98-e101
|
artikel
|
| 4 |
Does Physical Activity Play a Role in the Efficacy of RegoNivo for MSS-mCRC?
|
Srikrishna, Devabhaktuni
|
|
|
21 |
2 |
p. e76-e77
|
artikel
|
| 5 |
Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival
|
McClelland, Paul Hsin-ti
|
|
|
21 |
2 |
p. e135-e144
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
21 |
2 |
p. A1
|
artikel
|
| 7 |
Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer
|
Cadham, Breanne
|
|
|
21 |
2 |
p. e39-e48
|
artikel
|
| 8 |
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
|
Ciardiello, Davide
|
|
|
21 |
2 |
p. 141-148
|
artikel
|
| 9 |
Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II Study
|
Bertaut, Aurelie
|
|
|
21 |
2 |
p. e49-e61
|
artikel
|
| 10 |
Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol
|
Jafari, Mehraneh D.
|
|
|
21 |
2 |
p. 114-121
|
artikel
|
| 11 |
Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients
|
Zhou, Meijiao
|
|
|
21 |
2 |
p. e62-e75
|
artikel
|
| 12 |
Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers
|
Yu, Irene S.
|
|
|
21 |
2 |
p. 107-113
|
artikel
|
| 13 |
Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations
|
Sluckin, Tania C.
|
|
|
21 |
2 |
p. 80-88
|
artikel
|
| 14 |
Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review
|
Smilde, Bernard J.
|
|
|
21 |
2 |
p. 167-169
|
artikel
|
| 15 |
Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy
|
Sia, Joseph
|
|
|
21 |
2 |
p. e102-e112
|
artikel
|
| 16 |
Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer
|
Lee, Jeongshim
|
|
|
21 |
2 |
p. e78-e86
|
artikel
|
| 17 |
Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer
|
Kamposioras, Konstantinos
|
|
|
21 |
2 |
p. e117-e125
|
artikel
|
| 18 |
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
|
Hamers, Patricia A.H.
|
|
|
21 |
2 |
p. 154-166
|
artikel
|
| 19 |
Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective “Real-World Study”
|
Coutzac, Clélia
|
|
|
21 |
2 |
p. 132-140
|
artikel
|
| 20 |
Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity
|
Alonso Martinez, Salvador
|
|
|
21 |
2 |
p. 149-153
|
artikel
|
| 21 |
Table of contents
|
|
|
|
21 |
2 |
p. A3-A6
|
artikel
|
| 22 |
Targeting Hyaluronic Acid and Peritoneal Dissemination in Colorectal Cancer
|
Soliman, Faris
|
|
|
21 |
2 |
p. e126-e134
|
artikel
|
| 23 |
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
|
Folprecht, Gunnar
|
|
|
21 |
2 |
p. 170-174
|
artikel
|
| 24 |
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer
|
Bent, Alisha
|
|
|
21 |
2 |
p. 89-95
|
artikel
|
| 25 |
The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine
|
Aarnoutse, Romy
|
|
|
21 |
2 |
p. e87-e97
|
artikel
|
| 26 |
Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going
|
Sun, Chen
|
|
|
21 |
2 |
p. 71-79
|
artikel
|
| 27 |
Trifluridine/Tipiracil in Combination with Bevacizumab in First-Line for Metastatic Colorectal Cancer: A Way Forward. A Point of View Based on Cost-Effectiveness
|
Giuliani, Jacopo
|
|
|
21 |
2 |
p. e145-e147
|
artikel
|
| 28 |
Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy
|
Yang, Yufei
|
|
|
21 |
2 |
p. 96-106
|
artikel
|
Tijdschrift beschrijving